发明名称 縮合アミノジヒドロ−オキサジン誘導体
摘要 <p>A compound represented by the general formula: or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein Ring A is a C 6-14 aryl group or the like, L is -NR e CO- or the like (wherein R e is a hydrogen atom or the like), Ring B is a C 6-14 aryl group or the like, X is a C 1-3 alkylene group or the like, Y is a single bond or the like, Z is a C 1-3 alkylene group or the like, R 1 and R 2 are each independently a hydrogen atom or the like, and R 3 , R 4 , R 5 and R 6 are independently a hydrogen atom, a halogen atom or the like, has an A² production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by A² and typified by Alzheimer-type dementia.</p>
申请公布号 JP5651692(B2) 申请公布日期 2015.01.14
申请号 JP20120521035 申请日期 2010.07.21
申请人 发明人
分类号 C07D498/04;A61K31/5365;A61P25/28 主分类号 C07D498/04
代理机构 代理人
主权项
地址